Visit-to-visit variability of serum uric acid measurements and the risk of all-cause mortality in the general population

被引:9
|
作者
Tian, Xue [1 ,2 ]
Wang, Anxin [3 ,4 ]
Zuo, Yingting [1 ,2 ]
Chen, Shuohua [5 ]
Zhang, Licheng [1 ,2 ]
Wu, Shouling [5 ]
Luo, Yanxia [1 ,2 ]
机构
[1] Capital Med Univ, Sch Publ Hlth, Dept Epidmiol & Hlth Stat, 10 Xitoutiao, Beijing 100069, Peoples R China
[2] Beijing Municipal Key Lab Clin Epidmiol, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[5] North China Univ Sci & Technol, Kailuan Hosp, Dept Cardiol, 57 Xinhua East Rd, Tangshan 063000, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Serum uric acid; Variability; All-cause mortality; Risk factors; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR MORTALITY; BLOOD-PRESSURE; ASSOCIATION; PARAMETERS; OUTCOMES; DEATH; HBA1C; GOUT;
D O I
10.1186/s13075-021-02445-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Evidence on longitudinal variability of serum uric acid (SUA) and risk of all-cause mortality in the general population is limited, as many prior studies focused on a single measurement of SUA. Methods A total of 53,956 participants in the Kailuan study who underwent three health examinations during 2006 to 2010 were enrolled. Variability of SUA was measured using the coefficient of variation (primary index), standard deviation, average real variability, and variability independent of the mean. Cox proportional hazard regressions were used to calculate the hazard ratio (HR) and 95% confidence interval (CI) for the association of variability of SUA with subsequent risk of all-cause mortality, considering its magnitude and the direction and across different baseline SUA categories. Results Over a median follow-up of 7.04 years, 2728 participants died. The highest variability of SUA was associated with an increased risk of all-cause mortality, the HR was 1.33 (95% CI, 1.20-1.49) compared with the lowest variability. In this group, both a large fall (HR, 1.28; 95% CI, 1.14-1.44) and rise (HR, 1.18; 95% 1.05-1.32) in SUA were related to risk of all-cause mortality. These associations were similar across different baseline SUA categories. Consistent results were observed in alternative measures of SUA variability. Moreover, individuals with higher variability in SUA were more related to common risk factors than those with stable SUA. Conclusions Higher variability in SUA was independently associated with the risk of all-cause mortality irrespective of baseline SUA and direction of variability in the general population.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Changes in serum uric acid and the risk of cardiovascular disease and all-cause mortality in the general population
    Tian, Xue
    Wang, Anxin
    Zuo, Yingting
    Chen, Shuohua
    Ma, Yihan
    Han, Xu
    Zhang, Licheng
    Wu, Shouling
    Luo, Yanxia
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (05) : 1401 - 1409
  • [22] Visit-to-Visit Variability of Hemoglobin A1c in People Without Diabetes and Risk of Major Adverse Cardiovascular Events and All-Cause Mortality
    Ghouse, Jonas
    Skov, Morten W.
    Kanters, Jorgen K.
    Lind, Bent
    Isaksen, Jonas L.
    Blanche, Paul
    Haunso, Stig
    Kober, Lars
    Svendsen, Jesper H.
    Olesen, Morten S.
    Holst, Anders G.
    Gerds, Thomas A.
    Nielsen, Jonas B.
    [J]. DIABETES CARE, 2019, 42 (01) : 134 - 141
  • [23] The Association between Visit-to-Visit Variability of Fasting Plasma Glucose and All-Cause Mortality in Chinese Type 2 Diabetic Patients
    Liu, Yinan
    Yao, Baodong
    Fang, Hong
    Yan, Yujie
    Zhao, Yanping
    Chen, Yue
    [J]. DIABETES, 2015, 64 : A445 - A445
  • [24] Visit-To-Visit Variability In Blood Pressure In Patients With Rheumatoid Arthritis (RA) Vs General Population, and Its Impact On Cardiovascular Events and All-Cause Mortality In Rheumatoid Arthritis.
    Myasoedova, Elena
    Crowson, Cynthia S.
    Green, Abigail B.
    Matteson, Eric L.
    Gabriel, Sherine E.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S156 - S156
  • [25] Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial
    Hirakawa, Yoichiro
    Arima, Hisatomi
    Zoungas, Sophia
    Ninomiya, Toshiharu
    Cooper, Mark
    Hamet, Pavel
    Mancia, Giuseppe
    Poulter, Neil
    Harrap, Stephen
    Woodward, Mark
    Chalmers, John
    [J]. DIABETES CARE, 2014, 37 (08) : 2359 - 2365
  • [26] The Association between Visit-to-Visit Variability of Blood Pressure and All-Cause Mortality in Primary Care Chinese Type 2 Diabetic Patients
    Liu, Pu
    Fang, Hong
    Xu, Dongli
    Yan, Yujie
    Yao, Baodong
    Li, Jun
    [J]. DIABETES, 2017, 66 : A657 - A657
  • [27] Age and sex-specific associations of visit-to-visit variability of glycated hemoglobin A1c with all-cause mortality in patients with diabetes
    Yeh, Shu-Tin
    Ooi, Seng-Wei
    Chang, Ya-Hui
    Li, Chung-Yi
    Chen, Hua-Fen
    [J]. MEDICINE, 2022, 101 (33) : E29942
  • [28] Blood pressure variability within a single visit and all-cause mortality
    Papaioannou, T. G.
    Georgiopoulos, G.
    Stamatelopoulos, K. S.
    Protogerou, A. D.
    Alexandraki, K. I.
    Argyris, A.
    Vrachatis, D. A.
    Soulis, D.
    Papanikolaou, A.
    Manolesou, D.
    Daskalopoulou, S. S.
    Tousoulis, D.
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 2020, 78 (04): : 175 - 182
  • [29] VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY PREDICTS RISK OF ALL-CAUSE MORTALITY ESPECIALLY IN HYPERTENSIVE PATIENTS RECEIVING ANTIHYPERTENSIVE MEDICATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Li Sidong
    [J]. JOURNAL OF HYPERTENSION, 2018, 36 : E185 - E185
  • [30] Combined effect of visit-to-visit variations in heart rate and systolic blood pressure on all-cause mortality in hypertensive patients
    MaoXiang Zhao
    Siyu Yao
    Yao LI
    Miao Wang
    Chi Wang
    Cuijuan Yun
    Sijin Zhang
    Yizhen Sun
    Ziwei Hou
    Shouling Wu
    Hao Xue
    [J]. Hypertension Research, 2021, 44 : 1291 - 1299